NFKB1 and colorectal cancer: Since our recent study demonstrated that NF-κB and Nrf2 were expressed in not only inflammatory cells but also cancer cells in the TANAKA (AOM/DSS) model [34], these molecules may be the targets for cancer chemoprevention against colorectal cancer in the inflamed colon.